BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24888697)

  • 1. Automated quantification of apoptosis in B-cell chronic lymphoproliferative disorders: a prognostic variable obtained with the Cell-Dyn Sapphire (Abbott) automated hematology analyzer.
    Fumi M; Martins D; Pancione Y; Sale S; Rocco V
    Int J Lab Hematol; 2014 Dec; 36(6):628-35. PubMed ID: 24888697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations.
    Herishanu Y; Kay S; Joffe E; Ben-Ezra J; Baron S; Rotman R; Braunstein R; Dezorella N; Polliack A; Naparstek E; Perry C; Deutsch V; Katz BZ
    Leuk Res; 2014 Apr; 38(4):484-9. PubMed ID: 24565568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatic classification of atypical lymphoid B cells using digital blood image processing.
    Alférez S; Merino A; Mujica LE; Ruiz M; Bigorra L; Rodellar J
    Int J Lab Hematol; 2014 Aug; 36(4):472-80. PubMed ID: 24325784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
    Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
    Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Geyer SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE
    Mayo Clin Proc; 2007 Apr; 82(4):449-53. PubMed ID: 17418074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis in chronic lymphocytic leukaemia.
    Matutes E; Wotherspoon A; Catovsky D
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):367-84. PubMed ID: 17707827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
    Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
    Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE
    J Clin Oncol; 2009 Apr; 27(11):1844-9. PubMed ID: 19255329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective.
    Kumar N; Varma N; Varma S; Malhotra P
    Anal Quant Cytol Histol; 2009 Oct; 31(5):296-303. PubMed ID: 20701097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of apoptosis by the Abbott CD4000 hematology analyzer.
    Mentz F; Baudet S; Maloum K; Azgui Z; Sevin O; Vinsobre MF; Dujarric C; Brefort K; Chretien MC; Merle-Béral H
    Hematol Cell Ther; 1998 Oct; 40(5):183-8. PubMed ID: 9844812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic value of smudge cells (Gumprecht shadows) in chronic lymphocytic leukaemia].
    Szerafin L; Jakó J; Riskó F; Hevessy Z
    Orv Hetil; 2012 Nov; 153(44):1732-7. PubMed ID: 23103742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunophenotypic and molecular diagnosis of composite hairy cell leukaemia and chronic lymphocytic leukaemia.
    Liptrot S; O' Brien D; Langabeer SE; Quinn F; Mackarel AJ; Elder P; Vandenberghe E; Hayden PJ
    Med Oncol; 2013 Dec; 30(4):692. PubMed ID: 23979856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.